Presentation on MeTA, overview and lessons learned in pilot countries by MeTA's Executive Director, during the World Health Assembly (WHA), Geneva on19 May 2009.
Medicines Transparency Alliance (MeTA) : country progress and key lessonsMeTApresents
This presentation shares the progress to date of the pilot phase of the Medicines Transparency Alliance (MeTA) and was given by Wilbert Banneberg, Technical Director of the International MeTA Secretariat at the launch of MeTA Jordan in May 2009
Presentation on Concept and structure of MeTA by Wilbert Bannenberg, MeTA Technical Director during the MeTA Country Sharing Meeting, London, 8 December 2009.
Suomen sote-uudistuksella tavoitellaan hyvinvointi- ja terveyserojen kaventamista, palvelujen yhdenvertaisuuden ja saatavuuden parantamista sekä terveydenhoitokustannusten hillitsemistä.
Miten valinnanvapaus ja kilpailu tullaan toteuttamaan Suomen sote-uudistuksessa? Alivaltiosihteeri Tuomas Pöysti puhui aiheesta VATT-paivassa Säätytalolla 1.11.2016.
Prof. Carol Propperin esitys VATT-päivässä 1.11.2016.
Professori Carol Propper on taloustieteen professori Imperial College London -yliopistossa Lontoossa, Iso-Britanniassa. Professori Propperin tutkimus keskittyy kannustin- ja kilpailukysymyksiin terveydenhuoltomarkkinoilla sekä yleisemmin kannustimien suunnitteluun ja vaikutuksiin julkisella sektorilla sekä julkisen ja yksityisen markkinoiden rajapinnalla. Hän on kuuluisa erityisesti tutkimuksistaan, joissa on tarkasteltu kilpailun ja valinnanvapautta lisäävien uudistusten vaikutuksia terveydenhuollon toimintaan Iso-Britanniassa.
Prof. Martin Gaynorin esitys VATT-päivässä 1.11.2016
Gaynor on professori Carnegie Mellon yliopistossa, tutkija Britannian johtavassa, julkisen sektorin reformeihin keskittyvässä tutkimuslaitoksessa (Bristolin yliopiston Centre for Market and Public Organisation) ja jäsenenä NHS:n kilpailuasioita käsittelevässä asiantuntijapaneelissa.
Gaynor on tehnyt vaikutusvaltaisia tutkimuksia ja kirjoittanut laajasti terveydenhuoltomarkkinoiden toiminnasta, kilpailusta, kilpailua rajoittavista tekijöistä, tuottajien saamista korvauksista sekä Yhdysvalloissa että Briteissä.
Medicines Transparency Alliance (MeTA) : country progress and key lessonsMeTApresents
This presentation shares the progress to date of the pilot phase of the Medicines Transparency Alliance (MeTA) and was given by Wilbert Banneberg, Technical Director of the International MeTA Secretariat at the launch of MeTA Jordan in May 2009
Presentation on Concept and structure of MeTA by Wilbert Bannenberg, MeTA Technical Director during the MeTA Country Sharing Meeting, London, 8 December 2009.
Suomen sote-uudistuksella tavoitellaan hyvinvointi- ja terveyserojen kaventamista, palvelujen yhdenvertaisuuden ja saatavuuden parantamista sekä terveydenhoitokustannusten hillitsemistä.
Miten valinnanvapaus ja kilpailu tullaan toteuttamaan Suomen sote-uudistuksessa? Alivaltiosihteeri Tuomas Pöysti puhui aiheesta VATT-paivassa Säätytalolla 1.11.2016.
Prof. Carol Propperin esitys VATT-päivässä 1.11.2016.
Professori Carol Propper on taloustieteen professori Imperial College London -yliopistossa Lontoossa, Iso-Britanniassa. Professori Propperin tutkimus keskittyy kannustin- ja kilpailukysymyksiin terveydenhuoltomarkkinoilla sekä yleisemmin kannustimien suunnitteluun ja vaikutuksiin julkisella sektorilla sekä julkisen ja yksityisen markkinoiden rajapinnalla. Hän on kuuluisa erityisesti tutkimuksistaan, joissa on tarkasteltu kilpailun ja valinnanvapautta lisäävien uudistusten vaikutuksia terveydenhuollon toimintaan Iso-Britanniassa.
Prof. Martin Gaynorin esitys VATT-päivässä 1.11.2016
Gaynor on professori Carnegie Mellon yliopistossa, tutkija Britannian johtavassa, julkisen sektorin reformeihin keskittyvässä tutkimuslaitoksessa (Bristolin yliopiston Centre for Market and Public Organisation) ja jäsenenä NHS:n kilpailuasioita käsittelevässä asiantuntijapaneelissa.
Gaynor on tehnyt vaikutusvaltaisia tutkimuksia ja kirjoittanut laajasti terveydenhuoltomarkkinoiden toiminnasta, kilpailusta, kilpailua rajoittavista tekijöistä, tuottajien saamista korvauksista sekä Yhdysvalloissa että Briteissä.
Importance of the strategic & operation plans under the state cooperative agr...Maurice Dawson
Health Information Technology (IT) has become an important topic within the health community in the last several years. Technology has become intertwined in all facets of our lives from smart phones to simple robotics but the health care industry has not fully incorporated all these new technologies in every day practices. However the health care industry is actively working toward a systems concept that allows interoperability as the ones currently in fielded act as independent closed systems. The health care community aims to integrate tools such as tablets, laptops, and Open Source Software (OSS) applications that allow for paperless records to include increasing accuracy in the hospital room with the capture of patient data. Many states must update their status in relation to the Strategic and Operation Plan under the State Cooperative Agreement. Key items of importance are the following; governance, policy/legal, technical infrastructure, business and technical operations, communications/marketing, and relationships to Medicaid/Medicare. Moving forward it is essential to compare and contrast different states to provide a larger view of the status of being compliant with the Strategic and Operation Plan under the State Cooperative Agreement.
Open government platforms U.S. federal governmentInes Mergel
As part of the Open Government initiative, the U.S. federal government has set up a series of platforms to inform, educate, engage and collaborate with the public. This document categorizes the existing platforms based on their OG contributions, goals, audience, processes, and observed outcomes.
Regulatory Impact Analysis - Law & Economics courseWilliam Byrnes
Regulatory Impact Analysis - Law & Economics course
Effective regulation is regulation that achieves the policy objective that led to it being made.
Efficient regulation achieves these objectives at the lowest total cost to all members of society
Donna Cohen Ross - How CMS is Supporting the Use of Technology to Jump-Start ...Plain Talk 2015
"How CMS is Supporting the Use of Technology to Jump-Start Outreach and Enrollment in Health Coverage Programs" was presented at the Center for Health Literacy Conference 2011: Plain Talk in Complex Times by Donna Cohen Ross, Senior Policy Advisor, Office of the Center Director, Center for Medicaid, CHIP and Survey & Certification.
Description: The presenter will share how the Centers for Medicare & Medicaid Services (CMS) and its CHIPRA Outreach grantees are using technology to advance innovative approaches for identifying and enrolling people eligible for Medicaid and CHIP. How are new tools helping now and what will they mean for the future?
Is European market access becoming an incubator for rare disease development?...KateBenson18
FIECON's white paper 'Is European market access becoming an incubator for rare disease development?' explores the hypothesis that successful commercialisation in Europe is the biggest commercial opportunity for orphan drug manufacturers right now.
Helping Pharmas Manage Compliance Risks for Speaker ProgramsCognizant
To avoid stiff fees, reputation damage and the imposition of corporate integrity agreements (CIAs), pharmaceuticals companies need to monitor their speaker programs carefully for compliance to a suite of regulations. We identify those rules and outline a rigorous process based on relevant key performance indicators (KPIs) that will enable pharmas to head off these potential major hits to their bottom line.
Challenges to improve medicines transparency in GhanaMeTApresents
This is a presentation by Dr Daniel Kojo Arhinful at the launch of the Medicines Transparency Alliance (MeTA) in Ghana in November 2008. MeTA is a global alliance, working in 7 pilot countries. For more information, see www.MedicinesTransparency.org
Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. The Boot Camp afforded workshop participants an opportunity to discuss best practices, to learn from the experience of other experts and to create an enduring resource and toolkit that will serve the HIV vaccine field and beyond.
Product development refers to the multifaceted, long-term, highly regulated process that brings promising new drugs, vaccines and medical devices to the populations who most need them. In fields such as HIV vaccine development, where the absence of commercial incentives can make it difficult for companies to lead this process on their own, inventors need to work in partnership with diverse stakeholders and funders to maximize the social and economic impact of their research.
Ryan Wiley, PhD, President at Shift Health, delivered an overview of product development partnerships, which exhibit three common elements:
Defined governance mechanisms that enable appropriate participation in decision-making
Disciplined approach to communication among partners and with stakeholders
IP policies that balance the needs of individual partners with the objectives of the partnership.
Importance of the strategic & operation plans under the state cooperative agr...Maurice Dawson
Health Information Technology (IT) has become an important topic within the health community in the last several years. Technology has become intertwined in all facets of our lives from smart phones to simple robotics but the health care industry has not fully incorporated all these new technologies in every day practices. However the health care industry is actively working toward a systems concept that allows interoperability as the ones currently in fielded act as independent closed systems. The health care community aims to integrate tools such as tablets, laptops, and Open Source Software (OSS) applications that allow for paperless records to include increasing accuracy in the hospital room with the capture of patient data. Many states must update their status in relation to the Strategic and Operation Plan under the State Cooperative Agreement. Key items of importance are the following; governance, policy/legal, technical infrastructure, business and technical operations, communications/marketing, and relationships to Medicaid/Medicare. Moving forward it is essential to compare and contrast different states to provide a larger view of the status of being compliant with the Strategic and Operation Plan under the State Cooperative Agreement.
Open government platforms U.S. federal governmentInes Mergel
As part of the Open Government initiative, the U.S. federal government has set up a series of platforms to inform, educate, engage and collaborate with the public. This document categorizes the existing platforms based on their OG contributions, goals, audience, processes, and observed outcomes.
Regulatory Impact Analysis - Law & Economics courseWilliam Byrnes
Regulatory Impact Analysis - Law & Economics course
Effective regulation is regulation that achieves the policy objective that led to it being made.
Efficient regulation achieves these objectives at the lowest total cost to all members of society
Donna Cohen Ross - How CMS is Supporting the Use of Technology to Jump-Start ...Plain Talk 2015
"How CMS is Supporting the Use of Technology to Jump-Start Outreach and Enrollment in Health Coverage Programs" was presented at the Center for Health Literacy Conference 2011: Plain Talk in Complex Times by Donna Cohen Ross, Senior Policy Advisor, Office of the Center Director, Center for Medicaid, CHIP and Survey & Certification.
Description: The presenter will share how the Centers for Medicare & Medicaid Services (CMS) and its CHIPRA Outreach grantees are using technology to advance innovative approaches for identifying and enrolling people eligible for Medicaid and CHIP. How are new tools helping now and what will they mean for the future?
Is European market access becoming an incubator for rare disease development?...KateBenson18
FIECON's white paper 'Is European market access becoming an incubator for rare disease development?' explores the hypothesis that successful commercialisation in Europe is the biggest commercial opportunity for orphan drug manufacturers right now.
Helping Pharmas Manage Compliance Risks for Speaker ProgramsCognizant
To avoid stiff fees, reputation damage and the imposition of corporate integrity agreements (CIAs), pharmaceuticals companies need to monitor their speaker programs carefully for compliance to a suite of regulations. We identify those rules and outline a rigorous process based on relevant key performance indicators (KPIs) that will enable pharmas to head off these potential major hits to their bottom line.
Challenges to improve medicines transparency in GhanaMeTApresents
This is a presentation by Dr Daniel Kojo Arhinful at the launch of the Medicines Transparency Alliance (MeTA) in Ghana in November 2008. MeTA is a global alliance, working in 7 pilot countries. For more information, see www.MedicinesTransparency.org
Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. The Boot Camp afforded workshop participants an opportunity to discuss best practices, to learn from the experience of other experts and to create an enduring resource and toolkit that will serve the HIV vaccine field and beyond.
Product development refers to the multifaceted, long-term, highly regulated process that brings promising new drugs, vaccines and medical devices to the populations who most need them. In fields such as HIV vaccine development, where the absence of commercial incentives can make it difficult for companies to lead this process on their own, inventors need to work in partnership with diverse stakeholders and funders to maximize the social and economic impact of their research.
Ryan Wiley, PhD, President at Shift Health, delivered an overview of product development partnerships, which exhibit three common elements:
Defined governance mechanisms that enable appropriate participation in decision-making
Disciplined approach to communication among partners and with stakeholders
IP policies that balance the needs of individual partners with the objectives of the partnership.
Governance, transparency and Accountability~ MeTA objectives, approaches and ...MeTApresents
Presentation by Daniel Kojo Arhinful on Governance, transparency and Accountability~ MeTA objectives, approaches and role of CSOs, during the MeTA Ghana, CSOs and media orientation workshop, on 16 April 2009.
Governance transparency and accountabilityMeTApresents
'Governance transparency and accountability - role of civil society; MeTA objectives and approaches', presentation by Dr Daniel Kojo Arhinful during the MeTA Ghana, CSO & media orientation workshop, 16 April 2009.
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...Shift Health
Public-private partnerships (P3s) have become an increasingly pivotal—almost doctrinal—driver of R&D across the health sciences. But for all the advantages that have made P3s increasingly inevitable, these partnerships have not become less complex.
The Future of Transparency: Five Pillars for Global Successpharmacertify
In this webcast, PharmaCertify™, a division of NXLevel Solutions, teams with Berkeley Research Group to share practical approaches to help you navigate the complexities of US and global transparency reporting. You will get concrete, actionable advice on how your company can stay on top of global transparency challenges and:
- Ensure that your transparency processes are scalable and aligned to business practices
- Be prepared for mergers and integrations
- Boost the effectiveness of your data review process
- Manage TOV pre-disclosure
- Maximize your communication and education efforts
Speakers:
Pete Sandford, EVP, NXLevel Solutions
Mr. Sandford is the Executive Vice President and co-founder of NXLevel Solutions. He is a highly-regarded leader in the life sciences training industry and his experience in the field dates back nearly 25 years. Peter has been published in a number of industry journals and he has spoken extensively on the topic of effective and engaging training for the life sciences industry.
Katherine Norris, Director, Berkeley Research Group
Ms. Norris supports life sciences companies in a broad range of strategic and operation compliance objectives. As an industry professional, Ms. Norris has developed and overseen all aspects of compliance programs, including CIA implementation, global and domestic Aggregate Spend, HCP interactions, clinical post-market surveillance and general compliance.
Sets out the five core principles which guide the operation of the Medicines Transparency Alliance (MeTA) in efforts to increase transparency, accountability and governance around the supply of essential medicines.
MeTA pilot countries support needs and recommendationsMeTApresents
An overview of MeTA pilot countries support needs and recommendations, a presentation by Elodie Brandamir, MeTA Operations Director during the MeTA countries sharing meeting, London 2009
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
MeTA: Overview and lessons learned in pilot countries
1. Brian Elliott, Executive Director International MeTA Secretariat 19 th May 2009 Medicines Transparency Alliance (MeTA) Overview and lessons learned in pilot countries MeTA 08/04/2009
7. MeTA implementation process Stakeholders engaged MeTA Council formed MeTA Secretariat formed Pre-MoU work done MoU signed Work started GHANA JORDAN KYRGYZSTAN PERU PHILIPPINES UGANDA ZAMBIA
8. Specific Success or Milestone GHANA JORDAN KYRGYZSTAN PERU PHILIPPINES UGANDA ZAMBIA Establishment of the physical secretariat Full support of government and private sector Identifying the stakeholders and approval of the work plan Sign MoU because it is final point Successful forums and especially the CSO Forum in Jan 2009 Successful launch and the receiving of funds Successful launch and media interest